enVVeno Medical (NVNO) Revenue & Revenue Breakdown
enVVeno Medical Revenue Highlights
Main Segment (Y)
Royalty Income
Main Geography (Y)
Royalty Income
enVVeno Medical Revenue by Period
enVVeno Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2019-12-31 | $31.24K | -83.25% |
| 2018-12-31 | $186.55K | -55.80% |
| 2017-12-31 | $422.11K | -46.29% |
| 2016-12-31 | $785.91K | 100.00% |
| 2015-12-31 | - | - |
enVVeno Medical generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
enVVeno Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $824.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | -100.00% |
| 2019-03-31 | $31.24K | 2.56% |
| 2018-12-31 | $30.46K | -26.88% |
| 2018-09-30 | $41.66K | -50.02% |
| 2018-06-30 | $83.36K | 168.35% |
| 2018-03-31 | $31.07K | -82.26% |
| 2017-12-31 | $175.12K | 528.13% |
| 2017-09-30 | $27.88K | -28.14% |
| 2017-06-30 | $38.80K | -78.48% |
| 2017-03-31 | $180.31K | -40.86% |
| 2016-12-31 | $304.86K | 3.18% |
| 2016-09-30 | $295.47K | - |
enVVeno Medical generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
enVVeno Medical Revenue Breakdown
enVVeno Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 19 | Dec 18 |
|---|---|---|
| Royalty Income | $31.24K | $116.15K |
| Contract Research - Related Party | - | $70.40K |
enVVeno Medical's latest annual revenue breakdown by segment (product or service), as of Dec 19: Royalty Income (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 19 | Jun 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|
| Royalty Income | $31.24K | $31.24K | $28.06K | $28.06K | $28.96K |
| Contract Research - Related Party | - | - | $2.40K | $13.60K | $54.40K |
enVVeno Medical's latest quarterly revenue breakdown by segment (product or service), as of Sep 19: Royalty Income (100.00%).
enVVeno Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 19 | Dec 18 |
|---|---|---|
| Royalty Income | $31.24K | $116.15K |
| Contract Research - Related Party | - | $70.40K |
enVVeno Medical's latest annual revenue breakdown by geography, as of Dec 19: Royalty Income (100.00%).
Quarterly Revenue by Country
| Country | Jun 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|
| Royalty Income | $31.24K | $28.06K | $28.06K | $28.96K |
| Contract Research - Related Party | - | $2.40K | $13.60K | $54.40K |
enVVeno Medical's latest quarterly revenue breakdown by geography, as of Jun 19: Royalty Income (100.00%).
enVVeno Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LIVN | LivaNova | $1.15B | $318.60M |
| AXGN | AxoGen | $159.01M | $47.91M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SIEN | Sientra | $90.55M | $19.54M |
| RXST | RxSight | $89.08M | $45.52M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| IRIX | IRIDEX | $51.87M | $12.63M |
| AZYO | Elutia | $49.19M | $6.13M |
| LNSR | LENSAR | $42.16M | $10.59M |
| SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
| OSA | ProSomnus | $27.65M | $7.46M |
| TNON | Tenon Medical | $2.93M | $719.00K |
| PETV | PetVivo | $968.71K | $48.27K |
| TLIS | Talis Biomedical | $412.00K | - |
| AIMD | Ainos | $122.11K | - |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
| NVNO | enVVeno Medical | - | - |
NVNO Revenue FAQ
What is enVVeno Medical’s yearly revenue?
enVVeno Medical's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. NVNO's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is enVVeno Medical’s quarterly revenue?
enVVeno Medical's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). NVNO's quarterly revenue for Q4 2023 was $824K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is enVVeno Medical’s revenue growth rate?
enVVeno Medical's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.
What are enVVeno Medical’s revenue streams?
enVVeno Medical's revenue streams in c 19 are Royalty Income
What is enVVeno Medical’s main source of revenue?
For the fiscal year ending Dec 19, the largest source of revenue of enVVeno Medical was Royalty Income. This segment made a revenue of $31.24K, representing 100.00% of the company's total revenue.